These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34533937)

  • 21. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo.
    Zhou Q; Li Y; Jin J; Lang L; Zhu Z; Fang W; Chen X
    Biol Pharm Bull; 2012; 35(12):2170-9. PubMed ID: 23207769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor.
    Wen J; Luo Y; Gao H; Zhang L; Wang X; Huang J; Shang T; Zhou D; Wang D; Wang Z; Li P; Wang Z
    J Nanobiotechnology; 2021 Dec; 19(1):440. PubMed ID: 34930284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance.
    Shi J; Su Y; Liu W; Chang J; Zhang Z
    Int J Nanomedicine; 2017; 12():8257-8275. PubMed ID: 29180864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Mode Imaging Guided Multifunctional Theranosomes with Mitochondria Targeting for Photothermally Controlled and Enhanced Photodynamic Therapy in Vitro and in Vivo.
    Wang S; Guo F; Ji Y; Yu M; Wang J; Li N
    Mol Pharm; 2018 Aug; 15(8):3318-3331. PubMed ID: 29975536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
    Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
    Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a.
    Tang PM; Zhang DM; Xuan NH; Tsui SK; Waye MM; Kong SK; Fong WP; Fung KP
    Mol Cancer; 2009 Jul; 8():56. PubMed ID: 19646254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-Potentiated Photodynamic Theranostics for Synergistic Tumor Ablation and Precise Anticancer Efficacy Monitoring.
    Wang X; Tong J; He Z; Yang X; Meng F; Liang H; Zhang X; Luo L
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5476-5487. PubMed ID: 31910619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
    Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
    Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
    Shi Q; Zhang L; Liu M; Zhang X; Zhang X; Xu X; Chen S; Li X; Zhang J
    Biomaterials; 2015 Oct; 67():169-82. PubMed ID: 26218743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer.
    Bai F; Yin Y; Chen T; Chen J; Ge M; Lu Y; Xie F; Zhang J; Wu K; Liu Y
    Int J Nanomedicine; 2018; 13():1327-1339. PubMed ID: 29563790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination Organelle Mitochondrial Endoplasmic Reticulum Therapy (COMET) for Multidrug Resistant Breast Cancer.
    Milane LS; Dolare S; Ren G; Amiji M
    J Control Release; 2023 Nov; 363():435-451. PubMed ID: 37717658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
    Mohammad IS; He W; Yin L
    Pharm Res; 2018 Feb; 35(4):77. PubMed ID: 29488114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
    Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
    Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).
    Guo W; Chen Z; Feng X; Shen G; Huang H; Liang Y; Zhao B; Li G; Hu Y
    J Nanobiotechnology; 2021 May; 19(1):146. PubMed ID: 34011375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.